Joining us in this Cell Therapy Bioprocessing & Commercialization Podcast is Jessica Carmen, Business Development Manager of Lonza Walkersville. Jessica discusses supply chain & logistical challenges associated with commercialization, the evolution of the cell therapy field and where it is headed in the next five years, advancements in technology and much more. Below is a brief excerpt from the podcast, follow the links below to access the complete podcast and transcript.
Are there unique supply chain challenges associated with the commercialization of cell therapy products?
Yes, there are. There are many raw materials that are used in the manufacture of cell-based products that can pose a challenge when considering commercial needs, an example of which is the animal serum. Most cell types are culture-expanded in animal serums and there is a move in the field towards serum-free conditions. This is good from a supply chain and safety risk standpoint. However, most companies still employ animal serum in their processing and will need to consider the increasing costs and logistical challenges associated with the ever-increasing demand for this raw material.
Be sure to join us at Cell Therapy Bioprocessing & Commercialization in Alexandria, VA - September 30th to October 2nd, 2015. Register before 9/4 and save $300 with the code XB15188BLOG.
Share this article with your social network, just click below to share now!